Skip to content
2000
Volume 11, Issue 8
  • ISSN: 1389-2010
  • E-ISSN: 1873-4316

Abstract

Several recent studies have shown the protective effects of resveratrol in various experimental conditions and pathological animal models. Clinical studies also indicate the beneficial effects of resveratrol in different human diseases. Resveratrol produces a cascade against of events from the initial death-provoking signal, DNA fragmentation, and cell death. Researchers recognized the beneficial effect of resveratrol, as an important component, of the overall injury that occurs in various disorders such as oxidative stress, myocardial injury, anticancer activity, antidiabetic activity, and antihypercholesterolemic effects. Many mechanisms have been proposed for the initiation of protective effects of resveratrol in various pathological events, and considerable evidence exists to indicate that many mediators are involved in the resveratrol- induced protection. The present review focuses on the history, and the beneficial effects and mechanisms of resveratrol in oxidative stress, myocardial injury, anticancer-, antidiabetic- and antihypercholesterolemic activities, and discusses those therapeutic tools, which warrant becoming clinically important. s

Loading

Article metrics loading...

/content/journals/cpb/10.2174/138920110793262079
2010-12-01
2025-05-12
Loading full text...

Full text loading...

/content/journals/cpb/10.2174/138920110793262079
Loading

  • Article Type:
    Research Article
Keyword(s): acethylcholinesterase; Acute renal failure (ARF); age-related macular degeneration (AMD); alanine aminotransferase (ALT); Alzheimer's disease; aminoguanine (AG); AMP-activated protein kinase (AMPK); anti-apoptotic effects; antiapoptotic kinase; anticancer activity; antidiabetic activity; antihypercholesterolemic effects; antihypertrophic; antioxidant response element (ARE); antiproliferative; aspartate aminotransferase (AST); atherosclerosis; catechins; chemiluminescence; cyclooxygenase-2 (COX-2); death-provoking signal; DNA fragmentation; endotelin-1 (ET-1); estrogen receptor (ER); eucalyptus; flow-mediated dilation (FMD); French paradox; gallocatechins; highdensity lipoprotein cholesterol (HDL-C); hyperinsulinemia; Hyperlipidemia; hypoxia-inducible-factor 1 (HIF-1); insulin-like growth factor-1 (IGF-I); intracerebroventricular; ischemia/reperfusion; mitogen-activated protein kinase (MAPK); mulberries; multiple myeloma (MM); myocardial injury; neurodegenerative syndromes; neuromodulators; NG-nitro-L-arginine methyl ester (L-NAME); nitricoxide (NO); NO synthase (iNOS); oxidative stress; oxygen-glucose deprivation (OGD); phorbol ester (PMA); phosphatidylinositol (PI); phytoalexin; Polygonum cuspidatum; Preconditioning (PC); procyanidins; protoporphyrin; quercetin; Resveratrol; retinal pigment epithelium (RPE); Rheum rhaponticum; spinal cord ischemia; spruce; streptozotocin (STZ); subarachnoid hemorrhage, Parkinson's disease; tissue factor (TF); tissue glutathione; vascular endothelial growth factor (VEGF); Vitis vinifera
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test